302 related articles for article (PubMed ID: 18393268)
1. Conformationally restricted hydantoin-based peptidomimetics as inhibitors of caspase-3 with basic groups allowed at the S3 enzyme subsite.
Vázquez J; García-Jareño A; Mondragón L; Rubio-Martinez J; Pérez-Payá E; Albericio F
ChemMedChem; 2008 Jun; 3(6):979-85. PubMed ID: 18393268
[TBL] [Abstract][Full Text] [Related]
2. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
[TBL] [Abstract][Full Text] [Related]
3. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score.
Yoshimori A; Takasawa R; Tanuma S
BMC Pharmacol; 2004 May; 4():7. PubMed ID: 15154972
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase.
Nurbo J; Roos AK; Muthas D; Wahlström E; Ericsson DJ; Lundstedt T; Unge T; Karlén A
J Pept Sci; 2007 Dec; 13(12):822-32. PubMed ID: 17918768
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of potent thymidylate synthase X inhibitors.
Esra Onen F; Boum Y; Jacquement C; Spanedda MV; Jaber N; Scherman D; Myllykallio H; Herscovici J
Bioorg Med Chem Lett; 2008 Jun; 18(12):3628-31. PubMed ID: 18513963
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements.
Yeh VS; Kurukulasuriya R; Madar D; Patel JR; Fung S; Monzon K; Chiou W; Wang J; Jacobson P; Sham HL; Link JT
Bioorg Med Chem Lett; 2006 Oct; 16(20):5408-13. PubMed ID: 16890427
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.
Kravchenko DV; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
Eur J Med Chem; 2005 Dec; 40(12):1377-83. PubMed ID: 16169127
[TBL] [Abstract][Full Text] [Related]
9. In situ assembly of enzyme inhibitors using extended tethering.
Erlanson DA; Lam JW; Wiesmann C; Luong TN; Simmons RL; DeLano WL; Choong IC; Burdett MT; Flanagan WM; Lee D; Gordon EM; O'Brien T
Nat Biotechnol; 2003 Mar; 21(3):308-14. PubMed ID: 12563278
[TBL] [Abstract][Full Text] [Related]
10. Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
Sakai J; Yoshimori A; Nose Y; Mizoroki A; Okita N; Takasawa R; Tanuma S
Bioorg Med Chem; 2008 May; 16(9):4854-9. PubMed ID: 18387304
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel prodrugs of caspase inhibitors.
Charrier JD; Durrant SJ; Studley J; Lawes L; Weber P
Bioorg Med Chem Lett; 2012 Jan; 22(1):485-8. PubMed ID: 22104150
[TBL] [Abstract][Full Text] [Related]
12. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors.
Nakamura H; Watanabe M; Ban HS; Nabeyama W; Asai A
Bioorg Med Chem Lett; 2009 Jun; 19(12):3220-4. PubMed ID: 19428245
[TBL] [Abstract][Full Text] [Related]
14. Using peptidic inhibitors to systematically probe the S1' site of caspase-3 and caspase-7.
Goode DR; Sharma AK; Hergenrother PJ
Org Lett; 2005 Aug; 7(16):3529-32. PubMed ID: 16048334
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists.
Lippa B; Morris J; Corbett M; Kwan TA; Noe MC; Snow SL; Gant TG; Mangiaracina M; Coffey HA; Foster B; Knauth EA; Wessel MD
Bioorg Med Chem Lett; 2006 Jul; 16(13):3444-8. PubMed ID: 16632359
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors.
Palmer JT; Rydzewski RM; Mendonca RV; Sperandio D; Spencer JR; Hirschbein BL; Lohman J; Beltman J; Nguyen M; Liu L
Bioorg Med Chem Lett; 2006 Jul; 16(13):3434-9. PubMed ID: 16644215
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase.
Mbadugha BN; Seo J; Ji H; Martásek P; Roman LJ; Shea TM; Li H; Poulos TL; Silverman RB
Bioorg Med Chem; 2006 Jun; 14(11):3681-90. PubMed ID: 16480878
[TBL] [Abstract][Full Text] [Related]
18. Mycothiol disulfide reductase: solid phase synthesis and evaluation of alternative substrate analogues.
Stewart MJ; Jothivasan VK; Rowan AS; Wagg J; Hamilton CJ
Org Biomol Chem; 2008 Jan; 6(2):385-90. PubMed ID: 18175009
[TBL] [Abstract][Full Text] [Related]
19. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.
Oppong KA; Ellis CD; Laufersweiler MC; O'Neil SV; Wang Y; Soper DL; Baize MW; Wos JA; De B; Bosch GK; Fancher AN; Lu W; Suchanek MK; Wang RL; Demuth TP
Bioorg Med Chem Lett; 2005 Oct; 15(19):4291-4. PubMed ID: 16046125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
